First-line pembrolizumab monotherapy met the primary end point of PFS in dMMR advanced/recurrent endometrial cancer.
|Videos|November 27, 2017
Dr. Haldorsen Discusses the Challenges With Imaging in Endometrial Cancer
Author(s)Ingfrid Haldorsen, MD
Ingfrid Haldorsen, MD, University of Bergen, Haukeland University Hospital, discusses the challenges with imaging in endometrial cancer.
Advertisement
Ingfrid Haldorsen, MD, University of Bergen, Haukeland University Hospital, discusses the challenges with imaging in endometrial cancer.
Many novel biomarkers are derived from imaging, says Haldorsen, but it is not yet fully understood how they can be used to guide treatment.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Zidesamtinib in Pretreated ROS1+ NSCLC
2
Dr Patel on the Unmet Need in EGFR+ Transformed Small Cell Lung Cancer
3
Dr Hoffmann on the Significance of Efficacy Data for Sonrotoclax Plus Zanubrutinib in MCL
4
Dr Cooper on Biomarker Selection for DLL3-Targeted Therapies in ES-SCLC
5